Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: Role of interleukin-10 and monocyte chemoattractant protein 1

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 650-655

  Hogaboam, Cory M ^a   Steinhauser, Matthew L ^a   Schock, Harold ^a   Lukacs, Nicholas ^a   Strieter, Robert M ^a   Standiford, Theodore ^a   Kunkel, Steven L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENDOTOXEMIA; GROWTH INHIBITION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SEPSIS;

EID: 0031908733     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.650-655.1998     Document Type: Article

References (31)

1. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. 1991. Divergent efficacy of antibody to tumor necrosis factor-alpha in intra-vascular and peritonitis models of sepsis. J. Infect. Dis. 163:83-88.
2. Baggiolini, M., and C. A. Dahinden. 1994. CC chemokines in allergic inflammation, Immunol. Today 15:127-133.
3. Baker, C. C., I. H. Chaudry, H. O. Gaines, and A. E. Bauen 1983. Evaluation of factors affecting mortality rate after sepsis in a murinc cecal ligation and puncture model. Surgery 94:331-335.
4. Bean, A. G. D., R. A. Freiberg, S. Andrade, S. Menon, and A. Zlotnick. 1993. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61:4937-4939.
5. Burdick, M. D., S. L. Kunkel, P. M. Lincoln, C. A. Wilke, and R. M. Stricter. 1993. Specific ELISAs for the detection of human macrophage inflammatory protein-1 alpha and beta. Immunol. Invest. 226:441-446.
6. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-740.
7. Fiorentino, D. F., A. Zlotnik, T. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3820.
8. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3454.
9. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148:1792-1796.
10. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
11. Kilbourn, R. G., C. Szabo, and D. L. Traber. 1997. Beneficial versus detrimental effects of nitric oxide inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7:235-246.
12. Liaudet, L., F. Feihl, A. Rosselet, M. Markert, J. M. Hurni, and C. Perret. 1996. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxemia. Clin. Sci. 90:369-377.
13. Lin, P. J., C. H. Chang, and J. P. Chang. 1994. Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase. Chest 106:626-629.
14. Lukacs, N. W., S. W. Chensue, R. E. Smith, R. M. Stricter, K. Warmington, C. Wilke, and S. L. Kunkel. 1994. Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts. Am. J. Pathol. 144:711-718.
15. Moilanen, E., and H. Vapaatalo. 1995. Nitric oxide in inflammation and immune responses. Ann. Med. 27:359-367.
16. Moncada, S. 1992. The L-arginine:nitric oxide pathway. Acta Physiol. Scand. 145:201-227.
17. Nakono, Y., T. Kasahara, N. Mukaida, Y.-C. Ko, M. Nakano, and K. Matsushima. 1994. Protection against lethal bacterial infection in mice by monocyte-chemotactic and activating-factor. Infect. Immun. 62:377-383.
18. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
19. Petros, A., G. Lamb, A. Leone, S. Moncada, D. Bennett, and P. Valance. 1994. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28:34-39.
20. Rees, D. D., R. M. J. Palmer, R. Shulz, H. F. Hodson, and S. Moncada. 1990. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:746-752.
21. Rollins, B. J. 1991. JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine. Cancer Cells 3:517-524.
22. Rollins, B. J., and J. S. Pober. 1991. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am. J. Pathol. 138:1315-1319.
23. Spain, D. A., M. A. Wilson, and R. N. Garrison. 1994. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116:322-330.
24. Standiford, T. J., R. M. Stricter, N. W. Lukacs, and S. L. Kunkel. 1995. Neutralization of IL-10 increases lethality in endotoxemia. J. Immunol. 155:2222-2229.
25. Stone, R. 1994. Search for sepsis drugs goes on despite past failures. Science 264:365-367.
26. Szabo, C., G. J. Southan, and C. Thiemermann. 1994. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 91:12472-12476.
27. Tsai, W. C., R. M. Stricter, D. A. Zisman, J. M. Wilkowski, K. A. Bucknell, G.-W. Chen, and T. J. Standiford. 1997. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect. Immun. 65:1870-1875.
28. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Stricter, and K. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733-4738.
29. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Stricter, and S. L. Kunkel. 1997. Elevated levels of macrophage inflammatory protein-2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 65:3847-3851.
30. Zeiher, A. M., B. Fisslthaler, B. Schray-Utz, and R. Busse. 1995. Nitric oxide modulates the expression of monocyte chemoattractant protein-1 in cultured human endothelial cells. Circ. Res. 76:980-986.
31. Zisman, D. A., S. L. Kunkel, R. M. Stricter, W. C. Tsai, K. Bucknell, J. Wilkowski, and T. J. Standiford. 1997. MCP-1 protects mice in lethal endotoxemia. J. Clin. Invest. 99:2832-2836.